Report Detail

Pharma & Healthcare Global Peptides Market Insights and Forecast to 2026

  • RnM4152696
  • |
  • 24 August, 2020
  • |
  • Global
  • |
  • 111 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Peptides market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Peptides market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Peptides market is segmented into
Insulin
Teriparatide
Liraglutide
Leuprolide

Segment by Application, the Peptides market is segmented into
Diabetes
Infectious Diseases
Cancer
Osteoporosis

Regional and Country-level Analysis
The Peptides market is analysed and market size information is provided by regions (countries).
The key regions covered in the Peptides market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Peptides Market Share Analysis
Peptides market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Peptides business, the date to enter into the Peptides market, Peptides product introduction, recent developments, etc.

The major vendors covered:
Cipla Ltd.
Emcure Pharmaceuticals Pvt. Ltd.
Gland Pharma Limited
Troikaa Pharmaceuticals Ltd.
Biological E Limited
Bharat Biotech
Samarth Life Sciences Pvt. Ltd.
VHB Life Sciences Limited
Celon Laboratories Pvt. Ltd.
United Biotech (P) Limited


1 Study Coverage

  • 1.1 Peptides Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Peptides Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Peptides Market Size Growth Rate by Type
    • 1.4.2 Insulin
    • 1.4.3 Teriparatide
    • 1.4.4 Liraglutide
    • 1.4.5 Leuprolide
  • 1.5 Market by Application
    • 1.5.1 Global Peptides Market Size Growth Rate by Application
    • 1.5.2 Diabetes
    • 1.5.3 Infectious Diseases
    • 1.5.4 Cancer
    • 1.5.5 Osteoporosis
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Peptides Market Size, Estimates and Forecasts
    • 2.1.1 Global Peptides Revenue 2015-2026
    • 2.1.2 Global Peptides Sales 2015-2026
  • 2.2 Global Peptides, Market Size by Producing Regions: 2015 VS 2020 VS 2026
    • 2.2.1 Global Peptides Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Peptides Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Peptides Competitor Landscape by Players

  • 3.1 Peptides Sales by Manufacturers
    • 3.1.1 Peptides Sales by Manufacturers (2015-2020)
    • 3.1.2 Peptides Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Peptides Revenue by Manufacturers
    • 3.2.1 Peptides Revenue by Manufacturers (2015-2020)
    • 3.2.2 Peptides Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Peptides Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Peptides Revenue in 2019
    • 3.2.5 Global Peptides Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Peptides Price by Manufacturers
  • 3.4 Peptides Manufacturing Base Distribution, Product Types
    • 3.4.1 Peptides Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Peptides Product Type
    • 3.4.3 Date of International Manufacturers Enter into Peptides Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Peptides Market Size by Type (2015-2020)
    • 4.1.1 Global Peptides Sales by Type (2015-2020)
    • 4.1.2 Global Peptides Revenue by Type (2015-2020)
    • 4.1.3 Peptides Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Peptides Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Peptides Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Peptides Revenue Forecast by Type (2021-2026)
    • 4.2.3 Peptides Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Peptides Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Peptides Market Size by Application (2015-2020)
    • 5.1.1 Global Peptides Sales by Application (2015-2020)
    • 5.1.2 Global Peptides Revenue by Application (2015-2020)
    • 5.1.3 Peptides Price by Application (2015-2020)
  • 5.2 Peptides Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Peptides Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Peptides Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Peptides Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Peptides by Country
    • 6.1.1 North America Peptides Sales by Country
    • 6.1.2 North America Peptides Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Peptides Market Facts & Figures by Type
  • 6.3 North America Peptides Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Peptides by Country
    • 7.1.1 Europe Peptides Sales by Country
    • 7.1.2 Europe Peptides Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Peptides Market Facts & Figures by Type
  • 7.3 Europe Peptides Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Peptides by Region
    • 8.1.1 Asia Pacific Peptides Sales by Region
    • 8.1.2 Asia Pacific Peptides Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Peptides Market Facts & Figures by Type
  • 8.3 Asia Pacific Peptides Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Peptides by Country
    • 9.1.1 Latin America Peptides Sales by Country
    • 9.1.2 Latin America Peptides Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Peptides Market Facts & Figures by Type
  • 9.3 Central & South America Peptides Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Peptides by Country
    • 10.1.1 Middle East and Africa Peptides Sales by Country
    • 10.1.2 Middle East and Africa Peptides Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Peptides Market Facts & Figures by Type
  • 10.3 Middle East and Africa Peptides Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Cipla Ltd.
    • 11.1.1 Cipla Ltd. Corporation Information
    • 11.1.2 Cipla Ltd. Description and Business Overview
    • 11.1.3 Cipla Ltd. Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Cipla Ltd. Peptides Products Offered
    • 11.1.5 Cipla Ltd. Related Developments
  • 11.2 Emcure Pharmaceuticals Pvt. Ltd.
    • 11.2.1 Emcure Pharmaceuticals Pvt. Ltd. Corporation Information
    • 11.2.2 Emcure Pharmaceuticals Pvt. Ltd. Description and Business Overview
    • 11.2.3 Emcure Pharmaceuticals Pvt. Ltd. Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Emcure Pharmaceuticals Pvt. Ltd. Peptides Products Offered
    • 11.2.5 Emcure Pharmaceuticals Pvt. Ltd. Related Developments
  • 11.3 Gland Pharma Limited
    • 11.3.1 Gland Pharma Limited Corporation Information
    • 11.3.2 Gland Pharma Limited Description and Business Overview
    • 11.3.3 Gland Pharma Limited Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Gland Pharma Limited Peptides Products Offered
    • 11.3.5 Gland Pharma Limited Related Developments
  • 11.4 Troikaa Pharmaceuticals Ltd.
    • 11.4.1 Troikaa Pharmaceuticals Ltd. Corporation Information
    • 11.4.2 Troikaa Pharmaceuticals Ltd. Description and Business Overview
    • 11.4.3 Troikaa Pharmaceuticals Ltd. Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Troikaa Pharmaceuticals Ltd. Peptides Products Offered
    • 11.4.5 Troikaa Pharmaceuticals Ltd. Related Developments
  • 11.5 Biological E Limited
    • 11.5.1 Biological E Limited Corporation Information
    • 11.5.2 Biological E Limited Description and Business Overview
    • 11.5.3 Biological E Limited Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Biological E Limited Peptides Products Offered
    • 11.5.5 Biological E Limited Related Developments
  • 11.6 Bharat Biotech
    • 11.6.1 Bharat Biotech Corporation Information
    • 11.6.2 Bharat Biotech Description and Business Overview
    • 11.6.3 Bharat Biotech Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Bharat Biotech Peptides Products Offered
    • 11.6.5 Bharat Biotech Related Developments
  • 11.7 Samarth Life Sciences Pvt. Ltd.
    • 11.7.1 Samarth Life Sciences Pvt. Ltd. Corporation Information
    • 11.7.2 Samarth Life Sciences Pvt. Ltd. Description and Business Overview
    • 11.7.3 Samarth Life Sciences Pvt. Ltd. Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Samarth Life Sciences Pvt. Ltd. Peptides Products Offered
    • 11.7.5 Samarth Life Sciences Pvt. Ltd. Related Developments
  • 11.8 VHB Life Sciences Limited
    • 11.8.1 VHB Life Sciences Limited Corporation Information
    • 11.8.2 VHB Life Sciences Limited Description and Business Overview
    • 11.8.3 VHB Life Sciences Limited Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 VHB Life Sciences Limited Peptides Products Offered
    • 11.8.5 VHB Life Sciences Limited Related Developments
  • 11.9 Celon Laboratories Pvt. Ltd.
    • 11.9.1 Celon Laboratories Pvt. Ltd. Corporation Information
    • 11.9.2 Celon Laboratories Pvt. Ltd. Description and Business Overview
    • 11.9.3 Celon Laboratories Pvt. Ltd. Sales, Revenue and Gross Margin (2015-2020)
    • 11.9.4 Celon Laboratories Pvt. Ltd. Peptides Products Offered
    • 11.9.5 Celon Laboratories Pvt. Ltd. Related Developments
  • 11.10 United Biotech (P) Limited
    • 11.10.1 United Biotech (P) Limited Corporation Information
    • 11.10.2 United Biotech (P) Limited Description and Business Overview
    • 11.10.3 United Biotech (P) Limited Sales, Revenue and Gross Margin (2015-2020)
    • 11.10.4 United Biotech (P) Limited Peptides Products Offered
    • 11.10.5 United Biotech (P) Limited Related Developments
  • 11.1 Cipla Ltd.
    • 11.1.1 Cipla Ltd. Corporation Information
    • 11.1.2 Cipla Ltd. Description and Business Overview
    • 11.1.3 Cipla Ltd. Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Cipla Ltd. Peptides Products Offered
    • 11.1.5 Cipla Ltd. Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Peptides Market Estimates and Projections by Region
    • 12.1.1 Global Peptides Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Peptides Revenue Forecast by Regions 2021-2026
  • 12.2 North America Peptides Market Size Forecast (2021-2026)
    • 12.2.1 North America: Peptides Sales Forecast (2021-2026)
    • 12.2.2 North America: Peptides Revenue Forecast (2021-2026)
    • 12.2.3 North America: Peptides Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Peptides Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Peptides Sales Forecast (2021-2026)
    • 12.3.2 Europe: Peptides Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Peptides Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Peptides Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Peptides Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Peptides Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Peptides Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Peptides Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Peptides Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Peptides Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Peptides Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Peptides Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Peptides Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Peptides Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Peptides Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter's Five Forces Analysis
  • 13.5 Primary Interviews with Key Peptides Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Peptides Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Summary:
    Get latest Market Research Reports on Peptides. Industry analysis & Market Report on Peptides is a syndicated market report, published as Global Peptides Market Insights and Forecast to 2026. It is complete Research Study and Industry Analysis of Peptides market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    3,108.30
    4,662.45
    6,216.60
    3,627.00
    5,440.50
    7,254.00
    596,232.00
    894,348.00
    1,192,464.00
    325,377.00
    488,065.50
    650,754.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report